XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
DeepHealth, Inc.
Total RadNet, Inc.'s Equity
Common Stock
Common Stock
DeepHealth, Inc.
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022       57,723,125          
Beginning balance at Dec. 31, 2022 $ 491,452   $ 332,995 $ 6   $ 436,288 $ (20,677) $ (82,622) $ 158,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)       8,424          
Issuance of common stock upon exercise of options 72   72     72      
Issuance of common stock under the equity compensation plan (in shares)       1,069,324 21,956        
Stock-based compensation expense 21,381   21,381     21,381      
Issuance of common stock (in shares)       8,711,250          
Issuance of common stock 245,832   245,832 $ 1   245,831      
Issuance of common stock in connection with acquisitions (in shares)       314,130          
Issuance of common stock in connection with acquisitions     9,123     9,123      
Distributions paid to noncontrolling interests (3,523)               (3,523)
Contributions from noncontrolling interests 2,885               2,885
Sale of economic interests in majority owned subsidiary, net of taxes 2,217   2,217     2,217      
Change in cumulative foreign currency translation adjustment (385)   (385)       (385)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 2,765   2,765       2,765    
Other (2)   (3)     (2)   (1) 1
Net (loss) income 24,341   4,904         4,904 19,437
Ending balance (in shares) at Sep. 30, 2023       67,848,209          
Ending balance at Sep. 30, 2023 796,158   618,901 $ 7   714,910 (18,297) (77,719) 177,257
Beginning balance (in shares) at Jun. 30, 2023       67,669,564          
Beginning balance at Jun. 30, 2023 761,004   593,159 $ 7   703,593 (15,183) (95,258) 167,845
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)       3,424          
Issuance of common stock upon exercise of options 21   21     21      
Issuance of common stock under the equity compensation plan (in shares)       3,447 1,871        
Stock-based compensation expense 4,326   4,326     4,326      
Issuance of common stock (in shares)       0          
Issuance of common stock (370)   (370) $ 0   (370)      
Issuance of common stock in connection with acquisitions (in shares)       169,903          
Issuance of common stock in connection with acquisitions 5,123   5,123     5,123      
Contributions from noncontrolling interests 2,885               2,885
Sale of economic interests in majority owned subsidiary, net of taxes 2,217   2,217     2,217      
Change in cumulative foreign currency translation adjustment (4,035)   (4,035)       (4,035)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 921   921       921    
Other 0   (1)         (1) 1
Net (loss) income 24,066   17,540         17,540 6,526
Ending balance (in shares) at Sep. 30, 2023       67,848,209          
Ending balance at Sep. 30, 2023 $ 796,158   618,901 $ 7   714,910 (18,297) (77,719) 177,257
Beginning balance (in shares) at Dec. 31, 2023 67,956,318     67,956,318          
Beginning balance at Dec. 31, 2023 $ 813,359   630,695 $ 7   722,750 (12,484) (79,578) 182,664
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares) 60,306 9,377   60,605          
Issuance of common stock upon exercise of options $ 367   367     367      
Issuance of common stock under the equity compensation plan (in shares)       666,962 9,377        
Stock-based compensation expense 21,406   21,406     21,406      
Issuance of common stock (in shares)       5,232,500          
Issuance of common stock 218,385   218,385     218,385      
Issuance of common stock in connection with acquisitions (in shares)       95,019          
Issuance of common stock in connection with acquisitions 4,607   4,607     4,607      
Forfeiture of restricted stock and share cancellation (in shares)       (44,497)          
Forfeiture of restricted stock and share cancellation (38)   (38)     (38)      
Distributions paid to noncontrolling interests (2,423)   0           (2,423)
Contributions from noncontrolling interests 11,802   11,802     11,802      
Sale of economic interests in majority owned subsidiary, net of taxes 16,917               16,917
Change in cumulative foreign currency translation adjustment 2,399   2,399       2,399    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 8,242   8,242       8,242    
Net (loss) income $ 24,611   (2,552)         (2,552) 27,163
Ending balance (in shares) at Sep. 30, 2024 73,976,284     73,976,284          
Ending balance at Sep. 30, 2024 $ 1,119,634   895,313 $ 7   979,279 (1,843) (82,130) 224,321
Beginning balance (in shares) at Jun. 30, 2024       73,968,042          
Beginning balance at Jun. 30, 2024 1,092,840   880,966 $ 7   974,355 (8,057) (85,339) 211,874
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under the equity compensation plan (in shares)       9,075          
Stock-based compensation expense 4,727   4,727     4,727      
Forfeiture of restricted stock and share cancellation (in shares)       (833)          
Forfeiture of restricted stock and share cancellation (4)   (4)     (4)      
Contributions from noncontrolling interests 201   201     201      
Sale of economic interests in majority owned subsidiary, net of taxes 3,400               3,400
Change in cumulative foreign currency translation adjustment 5,228   5,228       5,228    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 986   986       986    
Net (loss) income $ 12,256   3,209         3,209 9,047
Ending balance (in shares) at Sep. 30, 2024 73,976,284     73,976,284          
Ending balance at Sep. 30, 2024 $ 1,119,634   $ 895,313 $ 7   $ 979,279 $ (1,843) $ (82,130) $ 224,321